Value Bridge — PRESBYTERIAN ST. LUKES MEDICAL CENT
Current $52M → Target $66M (+$14.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$51.7M
Current EBITDA
$66.0M
Target EBITDA
+$14.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.2M
Payer Mix Optimization
$7.8M
Cost to Collect Reduction
$2.6M
Clean Claim Improvement
$1.9M
Volume & Rate Growth
$12.9M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $52M to $66M. The highest-impact lever is Volume & Rate Growth at $5.2M probability-weighted.
IC talking point: "We see $14M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $157M in equity value creation."